Form 4: Twist Bioscience Exec Sells Shares for Tax Obligations

A Twist Bioscience executive sold 398 shares of common stock at $32.878 per share to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary of Twist Bioscience Corp (TWST), sold 398 shares of common stock.
• The transaction occurred on December 8, 2025, at a price of $32.878 per share.
• The sale was non-discretionary, mandated by the company's equity incentive plans to cover tax withholding obligations upon the vesting of Restricted Stock Units.
• Following this transaction, Dennis Cho beneficially owns 145,004 shares of common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary 'sell to cover' transaction for tax purposes, which is neutral in terms of company performance or insider sentiment. It does not indicate any positive or negative operational developments.

Future Outlook

NA

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically a 'sell to cover' for tax obligations. Such transactions are common across all industries for executives receiving equity compensation and do not typically reflect specific industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and not a signal of insider sentiment regarding the company's future performance.

Key Dates

Recommendation

This Form 4 details a routine 'sell to cover' transaction by an executive to satisfy tax obligations upon RSU vesting. It is a non-discretionary sale and does not reflect a change in the executive's confidence in the company or its future prospects. Therefore, it provides no new information that would warrant a change in investment recommendation; a 'hold' stance is maintained based solely on this filing.

Keywords

Twist Bioscience, TWST, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Dennis Cho, Equity Incentive Plan, Rule 10b5-1